[Relevance of the sedative-tranquilizing effect of l-tetrahydropalmatine to brain monoaminergic neurotransmitters].
D000470:Alkaloids / Q000494:pharmacology*; D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D001600:Berberine Alkaloids / Q000494:pharmacology*; D001679:Biogenic Amines; D005260:Female; D006801:Humans; D008297:Male; D051379:Mice; D018377:Neurotransmitter Agents / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D011956:Receptors, Cell Surface / Q000187:drug effects; D011954:Receptors, Dopamine / Q000187:drug effects; D011963:Receptors, GABA-A; D017981:Receptors, Neurotransmitter / Q000187:drug effects; D012110:Reserpine / Q000494:pharmacology; D013239:Stereotyped Behavior / Q000187:drug effects
D000470:Alkaloids; D014150:Antipsychotic Agents; D001600:Berberine Alkaloids; D001679:Biogenic Amines; D018377:Neurotransmitter Agents; D011956:Receptors, Cell Surface; D011954:Receptors, Dopamine; D011963:Receptors, GABA-A; D017981:Receptors, Neurotransmitter; C014215:tetrahydropalmatine; D012110:Reserpine